61 related articles for article (PubMed ID: 16507247)
1. [Effects of peroxisome proliferators PFOA on immune system of mice].
Yang J; Li A; Yang Q; Li X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Mar; 22(2):157-60. PubMed ID: 16507247
[TBL] [Abstract][Full Text] [Related]
2. [Influence of the peroxisome proliferator-activated receptor alpha on the development of T and B cells in mice].
Yang J; Li A; Yang Q; Li X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 May; 22(3):296-8. PubMed ID: 16643783
[TBL] [Abstract][Full Text] [Related]
3. Effects of peroxisome proliferators on the thymus and spleen of mice.
Yang Q; Xie Y; Depierre JW
Clin Exp Immunol; 2000 Nov; 122(2):219-26. PubMed ID: 11091278
[TBL] [Abstract][Full Text] [Related]
4. Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluoroctanoic acid in mice.
Yang Q; Xie Y; Eriksson AM; Nelson BD; DePierre JW
Biochem Pharmacol; 2001 Oct; 62(8):1133-40. PubMed ID: 11597582
[TBL] [Abstract][Full Text] [Related]
5. Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid.
Yang Q; Abedi-Valugerdi M; Xie Y; Zhao XY; Möller G; Nelson BD; DePierre JW
Int Immunopharmacol; 2002 Feb; 2(2-3):389-97. PubMed ID: 11811941
[TBL] [Abstract][Full Text] [Related]
6. Perfluorooctanoic acid alters T lymphocyte phenotypes and cytokine expression in mice.
Son HY; Lee S; Tak EN; Cho HS; Shin HI; Kim SH; Yang JH
Environ Toxicol; 2009 Dec; 24(6):580-8. PubMed ID: 19051282
[TBL] [Abstract][Full Text] [Related]
7. Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice.
Yang Q; Xie Y; Alexson SE; Nelson BD; DePierre JW
Biochem Pharmacol; 2002 May; 63(10):1893-900. PubMed ID: 12034374
[TBL] [Abstract][Full Text] [Related]
8. The atrophy and changes in the cellular compositions of the thymus and spleen observed in mice subjected to short-term exposure to perfluorooctanesulfonate are high-dose phenomena mediated in part by peroxisome proliferator-activated receptor-alpha (PPARalpha).
Qazi MR; Xia Z; Bogdanska J; Chang SC; Ehresman DJ; Butenhoff JL; Nelson BD; DePierre JW; Abedi-Valugerdi M
Toxicology; 2009 Jun; 260(1-3):68-76. PubMed ID: 19464571
[TBL] [Abstract][Full Text] [Related]
9. The relationship between liver peroxisome proliferation and adipose tissue atrophy induced by peroxisome proliferator exposure and withdrawal in mice.
Xie Y; Yang Q; Nelson BD; DePierre JW
Biochem Pharmacol; 2003 Sep; 66(5):749-56. PubMed ID: 12948855
[TBL] [Abstract][Full Text] [Related]
10. Suppression of antigen-specific antibody responses in mice exposed to perfluorooctanoic acid: Role of PPARα and T- and B-cell targeting.
DeWitt JC; Williams WC; Creech NJ; Luebke RW
J Immunotoxicol; 2016; 13(1):38-45. PubMed ID: 25594567
[TBL] [Abstract][Full Text] [Related]
11. Effects of estrogen receptor subtype-selective agonists on immune functions in ovariectomized mice.
Li J; McMurray RW
Int Immunopharmacol; 2006 Sep; 6(9):1413-23. PubMed ID: 16846835
[TBL] [Abstract][Full Text] [Related]
12. The ubiquitous environmental pollutant perfluorooctanoicacid inhibits feeding behavior via peroxisome proliferator-activated receptor-alpha.
Asakawa A; Toyoshima M; Harada KH; Fujimiya M; Inoue K; Koizumi A
Int J Mol Med; 2008 Apr; 21(4):439-45. PubMed ID: 18360689
[TBL] [Abstract][Full Text] [Related]
13. Effects of the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid, on apoptosis in human hepatoma HepG2 cells.
Shabalina IG; Panaretakis T; Bergstrand A; DePierre JW
Carcinogenesis; 1999 Dec; 20(12):2237-46. PubMed ID: 10590214
[TBL] [Abstract][Full Text] [Related]
14. Anti-inflammatory actions of perfluorooctanoic acid and peroxisome proliferator-activated receptors (PPAR) alpha and gamma in experimental acute pancreatitis.
Griesbacher T; Pommer V; Schuligoi R; Tiran B; Peskar BA
Int Immunopharmacol; 2008 Feb; 8(2):325-9. PubMed ID: 18182248
[TBL] [Abstract][Full Text] [Related]
15. Serum perfluorooctanoic acid and hepatic enzymes, lipoproteins, and cholesterol: a study of occupationally exposed men.
Gilliland FD; Mandel JS
Am J Ind Med; 1996 May; 29(5):560-8. PubMed ID: 8732932
[TBL] [Abstract][Full Text] [Related]
16. Molecular characterization of cytochrome P450 1A and 3A and the effects of perfluorooctanoic acid on their mRNA levels in rare minnow (Gobiocypris rarus) gills.
Liu Y; Wang J; Wei Y; Zhang H; Liu Y; Dai J
Aquat Toxicol; 2008 Jul; 88(3):183-90. PubMed ID: 18508136
[TBL] [Abstract][Full Text] [Related]
17. [Effects of antiepileptic drugs on immune system].
Basta-Kaim A; Budziszewska B; Lasoń W
Przegl Lek; 2008; 65(11):799-802. PubMed ID: 19205364
[TBL] [Abstract][Full Text] [Related]
18. Recovery of age-dependent immunological deterioration in old mice by thyroxine treatment.
El-Shaikh KA; Gabry MS; Othman GA
J Anim Physiol Anim Nutr (Berl); 2006 Jun; 90(5-6):244-54. PubMed ID: 16684146
[TBL] [Abstract][Full Text] [Related]
19. Quantitative characterizations of proteome: dependence on the number of proteins considered.
Randić M
J Proteome Res; 2006 Jul; 5(7):1575-9. PubMed ID: 16823964
[TBL] [Abstract][Full Text] [Related]
20. PEGylated liposomes elicit an anti-PEG IgM response in a T cell-independent manner.
Ishida T; Wang X; Shimizu T; Nawata K; Kiwada H
J Control Release; 2007 Oct; 122(3):349-55. PubMed ID: 17610982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
